191 related articles for article (PubMed ID: 19784413)
1. Distortion-product otoacoustic emissions and auditory brainstem responses sensitivity assessment in cisplatin-induced ototoxicity in rats.
Freitas MR; Silva VC; Brito GA; Carvalho Junior JV; Gomes Junior RM; Ribeiro Rde A
Braz J Otorhinolaryngol; 2009; 75(4):476-84. PubMed ID: 19784413
[TBL] [Abstract][Full Text] [Related]
2. The role of apoptosis in cisplatin-induced ototoxicity in rats.
De Freitas MR; Figueiredo AA; Brito GA; Leitao RF; Carvalho Junior JV; Gomes Junior RM; Ribeiro Rde A
Braz J Otorhinolaryngol; 2009; 75(5):745-52. PubMed ID: 19893946
[TBL] [Abstract][Full Text] [Related]
3. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals.
Sockalingam R; Freeman S; Cherny TL; Sohmer H
Am J Otol; 2000 Jul; 21(4):521-7. PubMed ID: 10912698
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent protection on cisplatin-induced ototoxicity - an electrophysiological study on the effect of three antioxidants in the Sprague-Dawley rat animal model.
Lorito G; Hatzopoulos S; Laurell G; Campbell KC; Petruccelli J; Giordano P; Kochanek K; Sliwa L; Martini A; Skarzynski H
Med Sci Monit; 2011 Aug; 17(8):BR179-186. PubMed ID: 21804453
[TBL] [Abstract][Full Text] [Related]
5. Effect of Transtympanic Injection of Melatonin on Cisplatin-Induced Ototoxicity.
Demir MG; Altıntoprak N; Aydın S; Kösemihal E; Başak K
J Int Adv Otol; 2015 Dec; 11(3):202-6. PubMed ID: 26915150
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
[TBL] [Abstract][Full Text] [Related]
7. Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity.
Olgun Y; Kırkım G; Kolatan E; Kıray M; Bagrıyanık A; Olgun A; Kızmazoglu DC; Ellıdokuz H; Serbetcıoglu B; Altun Z; Aktas S; Yılmaz O; Günerı EA
Laryngoscope; 2014 Mar; 124(3):760-6. PubMed ID: 23900991
[TBL] [Abstract][Full Text] [Related]
8. The Protective Effect of Cortexin on Cisplatin-Induced Ototoxicity.
Eroğlu O; Karlıdağ T; Kuloğlu T; Keleş E; Kaygusuz İ; Yalçın Ş
J Int Adv Otol; 2018 Apr; 14(1):27-33. PubMed ID: 29092803
[TBL] [Abstract][Full Text] [Related]
9. An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity.
Fernandez K; Wafa T; Fitzgerald TS; Cunningham LL
Hear Res; 2019 Apr; 375():66-74. PubMed ID: 30827780
[TBL] [Abstract][Full Text] [Related]
10. Co-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice.
Li Y; Ding D; Jiang H; Fu Y; Salvi R
Neurotox Res; 2011 Nov; 20(4):307-19. PubMed ID: 21455790
[TBL] [Abstract][Full Text] [Related]
11. Is there a gender-related susceptibility for cisplatin ototoxicity?
Kirkim G; Olgun Y; Aktas S; Kiray M; Kolatan E; Altun Z; Erçetin P; Bagriyanik A; Yilmaz O; Ellidokuz H
Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):2755-63. PubMed ID: 25214172
[TBL] [Abstract][Full Text] [Related]
12. Distortion-product otoacoustic emission test performance for ototoxicity monitoring.
Reavis KM; McMillan G; Austin D; Gallun F; Fausti SA; Gordon JS; Helt WJ; Konrad-Martin D
Ear Hear; 2011 Feb; 32(1):61-74. PubMed ID: 20625302
[TBL] [Abstract][Full Text] [Related]
13. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
Stavroulaki P; Apostolopoulos N; Segas J; Tsakanikos M; Adamopoulos G
Int J Pediatr Otorhinolaryngol; 2001 May; 59(1):47-57. PubMed ID: 11376818
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin ototoxicity in the Sprague Dawley rat evaluated by distortion product otoacoustic emissions.
Hatzopoulos S; Di Stefano M; Campbell KC; Falgione D; Ricci D; Rosignoli M; Finesso M; Albertin A; Previati M; Capitani S; Martini A
Audiology; 2001; 40(5):253-64. PubMed ID: 11688544
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal curcumin and vitamin E combination for the treatment of cisplatin-induced ototoxicity in rats.
Soyalıç H; Gevrek F; Koç S; Avcu M; Metin M; Aladağ İ
Int J Pediatr Otorhinolaryngol; 2016 Oct; 89():173-8. PubMed ID: 27619052
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin-induced ototoxicity and pharmacokinetics: preliminary findings in a dog model.
Sockalingam R; Filippich L; Charles B; Murdoch B
Ann Otol Rhinol Laryngol; 2002 Aug; 111(8):745-50. PubMed ID: 12184599
[TBL] [Abstract][Full Text] [Related]
17. Effects of ozone (O
Koçak HE; Taşkın Ü; Aydın S; Oktay MF; Altınay S; Çelik DS; Yücebaş K; Altaş B
Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4153-4159. PubMed ID: 27221387
[TBL] [Abstract][Full Text] [Related]
18. Oral Administration of Clinical Stage Drug Candidate SENS-401 Effectively Reduces Cisplatin-induced Hearing Loss in Rats.
Petremann M; Tran Van Ba C; Broussy A; Romanet C; Dyhrfjeld-Johnsen J
Otol Neurotol; 2017 Oct; 38(9):1355-1361. PubMed ID: 28796092
[TBL] [Abstract][Full Text] [Related]
19. The effect of resveratrol on the prevention of cisplatin ototoxicity.
Erdem T; Bayindir T; Filiz A; Iraz M; Selimoglu E
Eur Arch Otorhinolaryngol; 2012 Oct; 269(10):2185-8. PubMed ID: 22186767
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic etanercept treatment in cisplatin ototoxicity.
Dasli S; Topdag M; Mutlu A; Kara A; Ozturk M
Eur Arch Otorhinolaryngol; 2017 Oct; 274(10):3577-3583. PubMed ID: 28730299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
